TVARDI THERAPEUTICS, INC. Operating Lease Liability
TVARDI THERAPEUTICS, INC. (TVRD) had Operating Lease Liability of $145.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-14
- 2026-06-30: Operating Lease, Liability $145.00K.
- 2026-03-31: Operating Lease, Liability $174.00K.
- 2025-12-31: Operating Lease, Liability $201.00K.
- 2025-09-30: Operating Lease, Liability $228.00K.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-06-30 | $145.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $174.00K 10-Q · filed 2026-05-08 |
| 2025-12-31 | $201.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $228.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $254.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-13 |
| 2024-12-31 | $0.00 10-Q · filed 2025-05-13 |
| 2024-06-30 | $7.49M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $7.04M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $6.09M 10-K · filed 2024-03-06 |
| 2023-09-30 | $7.31M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $982.00K 10-Q · filed 2023-08-07 |
| 2023-03-31 | $1.46M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $1.92M 10-K · filed 2023-03-06 |
| 2022-09-30 | $2.37M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $2.82M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $3.25M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $3.67M 10-K · filed 2022-03-01 |
| 2021-09-30 | $4.09M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $4.50M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $4.89M 10-Q · filed 2021-05-10 |
| 2020-09-30 | $3.72M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $3.96M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $4.09M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $4.32M 10-K · filed 2020-02-27 |
| 2019-09-30 | $4.55M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $4.77M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $4.99M 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |